Inactive Instrument

Synergy Pharmaceuticals Inc Stock price Nasdaq

Equities

US8716393082

Biotechnology & Medical Research

Dynamic Chart
Managers TitleAgeSince
Corporate Officer/Principal - 08-06-30
Corporate Officer/Principal - 14-12-31
More insiders
Synergy Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of novel gastrointestinal (GI) therapies. Its gastrointestinal (GI) platform is based on uroguanylin. Uroguanylin physiologically regulates bowel function, fluid balance, and stool consistency.
More about the company
  1. Stock
  2. Equities
  3. Stock Synergy Pharmaceuticals Inc
  4. Stock Synergy Pharmaceuticals Inc - Nasdaq